Current Edition

drug development
Editorial Archive

Operational Challenges Associated with Biosimilar Drug Development

This article examines the current operational landscape of biosimilar clinical drug development and identifies opportunities to decrease the risks associated with increasing competition. With an …

Continue Reading →
biosimilars
Editorial Archive

FDA Makes First Move on biosimilars in the US

Regina Ballinger and Deborah Komlos from Thomson Reuters are submitting an interesting editorial titled FDA Makes First Move on Biosimilars in the US, and they …

Continue Reading →